Literature DB >> 19794403

Reduced occipital and prefrontal brain volumes in dysbindin-associated schizophrenia.

Gary Donohoe1, Thomas Frodl, Derek Morris, Ilaria Spoletini, Dara M Cannon, Andrea Cherubini, Carlo Caltagirone, Paola Bossù, Colm McDonald, Michael Gill, Aiden P Corvin, Gianfranco Spalletta.   

Abstract

A three-marker C-A-T dysbindin haplotype identified by Williams et al (PMID: 15066891) is associated with increased risk for schizophrenia, decreased mRNA expression, poorer cognitive performance, and early sensory processing deficits. We investigated whether this same dysbindin risk haplotype was also associated with structural variation in the gray matter volume (GMV). Using voxel-based morphometry, whole-volume analysis revealed significantly reduced GMVs in both the right dorsolateral prefrontal and left occipital cortex, corresponding to the behavioral findings of impaired spatial working memory and EEG findings of impaired visual processing already reported. These data provide important evidence of the influence of dysbindin risk variants on brain structure, and suggest a possible mechanism by which disease risk is being increased.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19794403      PMCID: PMC3055383          DOI: 10.1038/npp.2009.140

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  30 in total

1.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

2.  Genetic correlations between brain volumes and the WAIS-III dimensions of verbal comprehension, working memory, perceptual organization, and processing speed.

Authors:  Daniëlle Posthuma; Wim F C Baaré; Hilleke E Hulshoff Pol; René S Kahn; Dorret I Boomsma; Eco J C De Geus
Journal:  Twin Res       Date:  2003-04

3.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

4.  Candidate genes for schizophrenia: a survey of association studies and gene ranking.

Authors:  Jingchun Sun; Po-Hsiu Kuo; Brien P Riley; Kenneth S Kendler; Zhongming Zhao
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

5.  The Mini-Mental State Examination.

Authors:  M F Folstein; L N Robins; J E Helzer
Journal:  Arch Gen Psychiatry       Date:  1983-07

6.  Variation in the dysbindin gene and normal cognitive function in three independent population samples.

Authors:  M Luciano; F Miyajima; P A Lind; T C Bates; M Horan; S E Harris; M J Wright; W E Ollier; C Hayward; N Pendleton; A J Gow; P M Visscher; J M Starr; I J Deary; N G Martin; A Payton
Journal:  Genes Brain Behav       Date:  2008-12-03       Impact factor: 3.449

7.  Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization.

Authors:  Yukihiko Iizuka; Yoshitatsu Sei; Daniel R Weinberger; Richard E Straub
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

8.  DTNBP1 is associated with imaging phenotypes in schizophrenia.

Authors:  Katherine L Narr; Philip R Szeszko; Todd Lencz; Roger P Woods; Liberty S Hamilton; Owen Phillips; Delbert Robinson; Katherine E Burdick; Pamela DeRosse; Raju Kucherlapati; Paul M Thompson; Arthur W Toga; Anil K Malhotra; Robert M Bilder
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

9.  Early visual processing deficits in dysbindin-associated schizophrenia.

Authors:  Gary Donohoe; Derek W Morris; Pierfilippo De Sanctis; Elena Magno; Jennifer L Montesi; Hugh P Garavan; Ian H Robertson; Daniel C Javitt; Michael Gill; Aiden P Corvin; John J Foxe
Journal:  Biol Psychiatry       Date:  2007-10-22       Impact factor: 13.382

10.  Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.

Authors:  Konrad Talbot; Wess L Eidem; Caroline L Tinsley; Matthew A Benson; Edward W Thompson; Rachel J Smith; Chang-Gyu Hahn; Steven J Siegel; John Q Trojanowski; Raquel E Gur; Derek J Blake; Steven E Arnold
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

View more
  10 in total

Review 1.  Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene.

Authors:  Ariana P Mullin; Avanti Gokhale; Jennifer Larimore; Victor Faundez
Journal:  Mol Neurobiol       Date:  2011-04-26       Impact factor: 5.590

2.  Reduced habituation in patients with schizophrenia.

Authors:  Lisa E Williams; Jennifer Urbano Blackford; Andrew Luksik; Isabel Gauthier; Stephan Heckers
Journal:  Schizophr Res       Date:  2013-11-05       Impact factor: 4.939

3.  Differential relationships of mismatch negativity and visual p1 deficits to premorbid characteristics and functional outcome in schizophrenia.

Authors:  Tamara Friedman; Pejman Sehatpour; Elisa Dias; Megan Perrin; Daniel C Javitt
Journal:  Biol Psychiatry       Date:  2011-12-21       Impact factor: 13.382

Review 4.  Cognitive control deficits in schizophrenia: mechanisms and meaning.

Authors:  Tyler A Lesh; Tara A Niendam; Michael J Minzenberg; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

Review 5.  Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.

Authors:  Darrick T Balu; Joseph T Coyle
Journal:  Neurosci Biobehav Rev       Date:  2010-10-15       Impact factor: 8.989

Review 6.  Genomics and pharmacogenomics of schizophrenia.

Authors:  Ramón Cacabelos; Rocío Martínez-Bouza
Journal:  CNS Neurosci Ther       Date:  2010-08-16       Impact factor: 5.243

Review 7.  Imaging genetics and psychiatric disorders.

Authors:  R Hashimoto; K Ohi; H Yamamori; Y Yasuda; M Fujimoto; S Umeda-Yano; Y Watanabe; M Fukunaga; M Takeda
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

8.  Analysis of schizophrenia-related genes and electrophysiological measures reveals ZNF804A association with amplitude of P300b elicited by novel sounds.

Authors:  E C Del Re; S E Bergen; R I Mesholam-Gately; M A Niznikiewicz; J M Goldstein; T U Woo; M E Shenton; L J Seidman; R W McCarley; T L Petryshen
Journal:  Transl Psychiatry       Date:  2014-01-14       Impact factor: 6.222

9.  Increased dysbindin-1B isoform expression in schizophrenia and its propensity in aggresome formation.

Authors:  Yiliang Xu; Yuhui Sun; Haihong Ye; Li Zhu; Jianghong Liu; Xiaofeng Wu; Le Wang; Tingting He; Yan Shen; Jane Y Wu; Qi Xu
Journal:  Cell Discov       Date:  2015-11-10       Impact factor: 10.849

Review 10.  Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond.

Authors:  John L Waddington; Xuechu Zhen; Colm M P O'Tuathaigh
Journal:  Front Pharmacol       Date:  2020-01-29       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.